Small RNAs are modified with N-glycans and displayed on the surface of living cells RA Flynn, K Pedram, SA Malaker, PJ Batista, BAH Smith, AG Johnson, ... Cell 184 (12), 3109-3124. e22, 2021 | 347 | 2021 |
CD22 blockade restores homeostatic microglial phagocytosis in ageing brains JV Pluvinage, MS Haney, BAH Smith, J Sun, T Iram, L Bonanno, L Li, ... Nature 568 (7751), 187-192, 2019 | 343 | 2019 |
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans BAH Smith, CR Bertozzi Nature Reviews Drug Discovery 20 (3), 217-243, 2021 | 314 | 2021 |
Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication J Theruvath, M Menard, BAH Smith, MH Linde, GL Coles, GN Dalton, ... Nature Medicine 28 (2), 333-344, 2022 | 144 | 2022 |
MicroRNA-155–deficient dendritic cells cause less severe GVHD through reduced migration and defective inflammasome activation S Chen, BAH Smith, J Iype, A Prestipino, D Pfeifer, S Grundmann, ... Blood, The Journal of the American Society of Hematology 126 (1), 103-112, 2015 | 113 | 2015 |
Impact of mammalian target of rapamycin inhibition on lymphoid homing and tolerogenic function of nanoparticle-labeled dendritic cells following allogeneic hematopoietic cell … W Reichardt, C Dürr, D von Elverfeldt, E Jüttner, UV Gerlach, ... The Journal of Immunology 181 (7), 4770-4779, 2008 | 108 | 2008 |
Genome-wide CRISPR screens reveal a specific ligand for the glycan-binding immune checkpoint receptor Siglec-7 S Wisnovsky, L Möckl, SA Malaker, K Pedram, GT Hess, NM Riley, ... Proceedings of the National Academy of Sciences 118 (5), e2015024118, 2021 | 93 | 2021 |
Therapeutic activity of multiple common γ-chain cytokine inhibition in acute and chronic GVHD AK Hechinger, BAH Smith, R Flynn, K Hanke, C McDonald-Hyman, ... Blood, The Journal of the American Society of Hematology 125 (3), 570-580, 2015 | 84 | 2015 |
CRISPR-Cas9 screens identify regulators of antibody–drug conjugate toxicity CK Tsui, RM Barfield, CR Fischer, DW Morgens, A Li, BAH Smith, ... Nature chemical biology 15 (10), 949-958, 2019 | 67 | 2019 |
Transition to a mesenchymal state in neuroblastoma confers resistance to anti-GD2 antibody via reduced expression of ST8SIA1 NW Mabe, M Huang, GN Dalton, G Alexe, DA Schaefer, AC Geraghty, ... Nature Cancer 3 (8), 976-993, 2022 | 43 | 2022 |
MYC-driven synthesis of Siglec ligands is a glycoimmune checkpoint BAH Smith, A Deutzmann, KM Correa, CS Delaveris, R Dhanasekaran, ... Proceedings of the National Academy of Sciences 120 (11), e2215376120, 2023 | 21 | 2023 |
Mammalian Y RNAs are modified at discrete guanosine residues with N-glycans RA Flynn, BAH Smith, AG Johnson, K Pedram, BM George, SA Malaker, ... bioRxiv, 787614, 2019 | 15 | 2019 |
Anti-GD2 antibody disrupts GD2: Siglec-7 interactions and synergizes with CD47 blockade to mediate tumor eradication J Theruvath, M Menard, BAH Smith, MH Linde, GL Coles, W Wu, L Kiru, ... BioRxiv, 2021.03. 19.436221, 2021 | 3 | 2021 |
Beta-2 adrenergic receptor agonism alters astrocyte phagocytic activity and has potential applications to psychiatric disease ER Bowen, P DiGiacomo, HP Fraser, K Guttenplan, BAH Smith, ... Discover Mental Health 3 (1), 27, 2023 | | 2023 |
Compositions and methods for treating age-related diseases A Wyss-Coray, JV Pluvinage, MC Bassik, M Haney, B Smith, C Bertozzi | | 2019 |